HDDO-1614 Bio Equivalence Study

Inclusion Criteria: * Body weight 50kg ≤ / BMI=18\~29kg/㎡ * A person who is determined to be eligible for the test through a physical examination or an interview * Those who have been judged to be eligible for the clinical laboratory tests such as hematology test, blood chemistry test, urine test, and serology test Exclusion Criteria: * Patients with clinically significant liver, pancreas, kidney, nervous system, respiratory, endocrine, hematologic, mental, cardiovascular * Patients with a history of gastrointestinal disorders or history of gastrointestinal surgery that may affect the absorption of pharmaceuticals for clinical trials * Any person who shows any of the following results in the screening test 1. AST or ALT \> 2 times upper limit of normal range 2. Total Bilirubin \> 2.0mg/dL 3. Glomerular filtration Rate(eGFR) \< 60mL/min/1.7㎡ * Those who show signs of hypotension (systolic blood pressure ≤ 100mm Hg or diastolic blood pressure ≤ 55mmHg) or Hypertension (systolic blood pressure ≥ 150mmHg or diastolic blood pressure ≥ 95mmHg) * Those who have a history of drug or who have a positive urine drug test